Processa Pharmaceuticals Stock Technical Analysis
| PCSA Stock | USD 2.33 0.07 3.10% |
As of the 10th of February, Processa Pharmaceuticals holds the Coefficient Of Variation of (2,825), risk adjusted performance of (0.02), and Variance of 357.6. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Processa Pharmaceuticals, as well as the relationship between them.
Processa Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Processa, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProcessaProcessa Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Processa Pharmaceuticals. Anticipated expansion of Processa directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Processa Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Processa Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Processa Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Processa Pharmaceuticals' market price to deviate significantly from intrinsic value.
It's important to distinguish between Processa Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Processa Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Processa Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.
Processa Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Processa Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Processa Pharmaceuticals.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Processa Pharmaceuticals on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Processa Pharmaceuticals or generate 0.0% return on investment in Processa Pharmaceuticals over 90 days. Processa Pharmaceuticals is related to or competes with Briacell Therapeutics, Curis, Palisade Bio, Hoth Therapeutics, Moleculin Biotech, Athira Pharma, and Allarity Therapeutics. Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products ... More
Processa Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Processa Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Processa Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 164.28 | |||
| Value At Risk | (14.08) | |||
| Potential Upside | 10.24 |
Processa Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Processa Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Processa Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Processa Pharmaceuticals historical prices to predict the future Processa Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.67) | |||
| Total Risk Alpha | (2.63) | |||
| Treynor Ratio | 6.08 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Processa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Processa Pharmaceuticals February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | 6.09 | |||
| Mean Deviation | 8.44 | |||
| Coefficient Of Variation | (2,825) | |||
| Standard Deviation | 18.91 | |||
| Variance | 357.6 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.67) | |||
| Total Risk Alpha | (2.63) | |||
| Treynor Ratio | 6.08 | |||
| Maximum Drawdown | 164.28 | |||
| Value At Risk | (14.08) | |||
| Potential Upside | 10.24 | |||
| Skewness | 4.33 | |||
| Kurtosis | 31.3 |
Processa Pharmaceuticals Backtested Returns
Processa Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0354, which implies the firm had a -0.0354 % return per unit of risk over the last 3 months. Processa Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Processa Pharmaceuticals' Risk Adjusted Performance of (0.02), variance of 357.6, and Coefficient Of Variation of (2,825) to confirm the risk estimate we provide. The company holds a Beta of -0.11, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Processa Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Processa Pharmaceuticals is likely to outperform the market. At this point, Processa Pharmaceuticals has a negative expected return of -0.67%. Please make sure to check Processa Pharmaceuticals' accumulation distribution, and the relationship between the potential upside and day median price , to decide if Processa Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.72 |
Good predictability
Processa Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Processa Pharmaceuticals time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Processa Pharmaceuticals price movement. The serial correlation of 0.72 indicates that around 72.0% of current Processa Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.17 |
Processa Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Processa Pharmaceuticals Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Processa Pharmaceuticals across different markets.
About Processa Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Processa Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Processa Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Processa Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Processa Pharmaceuticals. By analyzing Processa Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Processa Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Processa Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
Processa Pharmaceuticals February 10, 2026 Technical Indicators
Most technical analysis of Processa help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Processa from various momentum indicators to cycle indicators. When you analyze Processa charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | 6.09 | |||
| Mean Deviation | 8.44 | |||
| Coefficient Of Variation | (2,825) | |||
| Standard Deviation | 18.91 | |||
| Variance | 357.6 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.67) | |||
| Total Risk Alpha | (2.63) | |||
| Treynor Ratio | 6.08 | |||
| Maximum Drawdown | 164.28 | |||
| Value At Risk | (14.08) | |||
| Potential Upside | 10.24 | |||
| Skewness | 4.33 | |||
| Kurtosis | 31.3 |
Processa Pharmaceuticals February 10, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Processa stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2,741 | ||
| Daily Balance Of Power | 0.32 | ||
| Rate Of Daily Change | 1.03 | ||
| Day Median Price | 2.33 | ||
| Day Typical Price | 2.33 | ||
| Price Action Indicator | 0.04 |
Complementary Tools for Processa Stock analysis
When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |